296 related articles for article (PubMed ID: 25446919)
21. Resolvin E1 protects the rat heart against reperfusion injury.
Keyes KT; Ye Y; Lin Y; Zhang C; Perez-Polo JR; Gjorstrup P; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H153-64. PubMed ID: 20435846
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
[TBL] [Abstract][Full Text] [Related]
23. Ethyl pyruvate attenuates myocardial ischemia-reperfusion injury exacerbated by hyperglycemia via retained inhibitory effect on HMGB1.
Soh S; Jun JH; Song JW; Shin EJ; Kwak YL; Shim JK
Int J Cardiol; 2018 Feb; 252():156-162. PubMed ID: 29169909
[TBL] [Abstract][Full Text] [Related]
24. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion.
Tada H; Kagaya Y; Takeda M; Ohta J; Asaumi Y; Satoh K; Ito K; Karibe A; Shirato K; Minegishi N; Shimokawa H
Cardiovasc Res; 2006 Aug; 71(3):466-77. PubMed ID: 16781691
[TBL] [Abstract][Full Text] [Related]
25. Hyperglycemia attenuates myocardial preconditioning of remifentanil.
Kim HS; Kim SY; Kwak YL; Hwang KC; Shim YH
J Surg Res; 2012 May; 174(2):231-7. PubMed ID: 21392805
[TBL] [Abstract][Full Text] [Related]
26. Salvianolic acid A demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury.
Pan H; Li D; Fang F; Chen D; Qi L; Zhang R; Xu T; Sun H
J Cardiovasc Pharmacol; 2011 Nov; 58(5):535-42. PubMed ID: 21795988
[TBL] [Abstract][Full Text] [Related]
27. The protective effects of emulsified isoflurane on myocardial ischemia and reperfusion injury in rats.
Hu ZY; Luo NF; Liu J
Can J Anaesth; 2009 Feb; 56(2):115-25. PubMed ID: 19247759
[TBL] [Abstract][Full Text] [Related]
28. A labdane diterpene exerts ex vivo and in vivo cardioprotection against post-ischemic injury: involvement of AKT-dependent mechanisms.
Cuadrado-Berrocal I; Gómez-Gaviro MV; Benito Y; Barrio A; Bermejo J; Fernández-Santos ME; Sánchez PL; Desco M; Fernández-Avilés F; Fernández-Velasco M; Boscá L; de Las Heras B
Biochem Pharmacol; 2015 Feb; 93(4):428-39. PubMed ID: 25557296
[TBL] [Abstract][Full Text] [Related]
29. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
[TBL] [Abstract][Full Text] [Related]
30. Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase II independent of ERK/GSK-3β pathway.
Min J; Wei C
Biomed Pharmacother; 2017 Mar; 87():419-426. PubMed ID: 28068632
[TBL] [Abstract][Full Text] [Related]
31. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion.
Lipsic E; van der Meer P; Henning RH; Suurmeijer AJ; Boddeus KM; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
J Cardiovasc Pharmacol; 2004 Oct; 44(4):473-9. PubMed ID: 15454856
[TBL] [Abstract][Full Text] [Related]
32. (-)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions.
Wu Y; Xia ZY; Zhao B; Leng Y; Dou J; Meng QT; Lei SQ; Chen ZZ; Zhu J
Int J Mol Med; 2017 Aug; 40(2):389-399. PubMed ID: 28714516
[TBL] [Abstract][Full Text] [Related]
33. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways.
Rafiee P; Shi Y; Su J; Pritchard KA; Tweddell JS; Baker JE
Basic Res Cardiol; 2005 May; 100(3):187-97. PubMed ID: 15611843
[TBL] [Abstract][Full Text] [Related]
34. Effective glycaemic control critically determines insulin cardioprotection against ischaemia/reperfusion injury in anaesthetized dogs.
Yu Q; Zhou N; Nan Y; Zhang L; Li Y; Hao X; Xiong L; Lau WB; Ma XL; Wang H; Gao F
Cardiovasc Res; 2014 Jul; 103(2):238-47. PubMed ID: 24845581
[TBL] [Abstract][Full Text] [Related]
35. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
[TBL] [Abstract][Full Text] [Related]
36. Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway.
Miki T; Miura T; Tanno M; Nishihara M; Naitoh K; Sato T; Takahashi A; Shimamoto K
Basic Res Cardiol; 2007 Mar; 102(2):163-70. PubMed ID: 16944359
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of RACK1 is associated with cardiomyocyte apoptosis after myocardial ischemia/reperfusion injury in adult rats.
Qian L; Shi J; Zhang C; Lu J; Lu X; Wu K; Yang C; Yan D; Zhang C; You Q; Liu X
In Vitro Cell Dev Biol Anim; 2016 Mar; 52(3):305-313. PubMed ID: 26659395
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of TIMP3 Protects Against Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Apoptosis Through ROS/Mapks Pathway.
Liu H; Jing X; Dong A; Bai B; Wang H
Cell Physiol Biochem; 2017; 44(3):1011-1023. PubMed ID: 29179205
[TBL] [Abstract][Full Text] [Related]
39. Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats.
Ren-an Q; Juan L; Chuyuan L; Wenjuan F; Chunyan H; Xuemei Y; Lin H; Hong N
J Ethnopharmacol; 2014 Oct; 156():190-8. PubMed ID: 25178948
[TBL] [Abstract][Full Text] [Related]
40. Effect of Salvia miltiorrhiza and ligustrazine injection on myocardial ischemia/reperfusion and hypoxia/reoxygenation injury.
Huang W; Yang Y; Zeng Z; Su M; Gao Q; Zhu B
Mol Med Rep; 2016 Nov; 14(5):4537-4544. PubMed ID: 27748867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
